Bullock R - Search Results

1

Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.

Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, Potkin SG. Gauthier S, et al. Among authors: bullock r. Curr Med Res Opin. 2003;19(8):707-14. doi: 10.1185/030079903125002450. Curr Med Res Opin. 2003. PMID: 14687441 Review.

2

Galantamine demonstrates efficacy and safety in elderly patients with Alzheimer disease.

Marcusson J, Bullock R, Gauthier S, Kurz A, Schwalen S. Marcusson J, et al. Among authors: bullock r. Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17 Suppl 3:S86-91. doi: 10.1097/00002093-200307003-00005. Alzheimer Dis Assoc Disord. 2003. PMID: 14512822

3

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.

Bullock R, Touchon J, Bergman H, Gambina G, He Y, Rapatz G, Nagel J, Lane R. Bullock R, et al. Curr Med Res Opin. 2005 Aug;21(8):1317-27. doi: 10.1185/030079905X56565. Curr Med Res Opin. 2005. PMID: 16083542 Clinical Trial.

4

Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.

Bullock R, Bergman H, Touchon J, Gambina G, He Y, Nagel J, Lane R. Bullock R, et al. Curr Med Res Opin. 2006 Mar;22(3):483-94. doi: 10.1185/030079906X89685. Curr Med Res Opin. 2006. PMID: 16574032 Clinical Trial.

5

Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.

Emre M, Bernabei R, Blesa R, Bullock R, Cunha L, Daniëls H, Dziadulewicz E, Förstl H, Frölich L, Gabryelewicz T, Levin O, Lindesay J, Martínez-Lage P, Monsch A, Tsolaki M, van Laar T. Emre M, et al. Among authors: bullock r. CNS Neurosci Ther. 2010 Aug;16(4):246-53. doi: 10.1111/j.1755-5949.2010.00141.x. Epub 2010 Apr 16. CNS Neurosci Ther. 2010. PMID: 20370805 Free PMC article. Review.

6

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.

Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Erkinjuntti T, et al. Among authors: bullock r. Lancet. 2002 Apr 13;359(9314):1283-90. doi: 10.1016/S0140-6736(02)08267-3. Lancet. 2002. PMID: 11965273 Clinical Trial.

7

Cholinesterase inhibition: is there evidence for disease-modifying effects?

Shanks M, Kivipelto M, Bullock R, Lane R. Shanks M, et al. Among authors: bullock r. Curr Med Res Opin. 2009 Oct;25(10):2439-46. doi: 10.1185/03007990903209332. Curr Med Res Opin. 2009. PMID: 19678754 Review.

8

Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.

Bullock R, Cameron A. Bullock R, et al. Curr Med Res Opin. 2002;18(5):258-64. doi: 10.1185/030079902125000813. Curr Med Res Opin. 2002. PMID: 12240787

9

Trial designs likely to meet valid long-term Alzheimer's disease progression effects: learning from the past, preparing for the future.

Kemp AS, Grossberg GT, Romano SJ, Arnold DL, Ryan JM, Bullock R, Streiner DL. Kemp AS, et al. Among authors: bullock r. Int J Alzheimers Dis. 2009 Dec 22;2009:949271. doi: 10.4061/2009/949271. Int J Alzheimers Dis. 2009. PMID: 20798873 Free PMC article.

10

Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty.

Robert PH, König A, Amieva H, Andrieu S, Bremond F, Bullock R, Ceccaldi M, Dubois B, Gauthier S, Kenigsberg PA, Nave S, Orgogozo JM, Piano J, Benoit M, Touchon J, Vellas B, Yesavage J, Manera V. Robert PH, et al. Among authors: bullock r. Front Aging Neurosci. 2014 Mar 24;6:54. doi: 10.3389/fnagi.2014.00054. eCollection 2014. Front Aging Neurosci. 2014. PMID: 24715864 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters